Aelis Farma
http://www.aelisfarma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Aelis Farma
IPOs Collapse In The Second Quarter
Biotechs have had a difficult time raising cash through flotations over the past quarter, with one stepping away altogether.
Midatech Bets on Bioasis Merger For Survival
With just enough cash to stay afloat until the first quarter, Midatech is linking up with US-based, Canada-listed Bioasis to create a new rare disease player, Biodexa.
Spain's Oryzon Bucks Trend To Seek NASDAQ Listing
The year to date has been a depressing period for initial public offerings, especially in Europe, but the Madrid-based epigenetics specialist is evaluating whether to head west and list in the US.
Indivior Inks Pact With Aelis For Cannabis Use Disorder Therapy
A market leader in opioid addiction, Indivior is expanding into the cannabis abuse space which is increasing exponentially due to widespread legalization of recreational use for the drug.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice